Medicare Enrolled
Dr. Haider Khadim, MD
Medical Oncology · Syracuse, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khadim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khadim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khadim
Dr. Haider Khadim is a medical oncology specialist in Syracuse, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Khadim performed 63,959 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khadim received a total of $49,832 from 83 pharmaceutical and/or device companies across 751 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khadim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 2% volume in NY
$49,832 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗63,959
Medicare services
Top 2% in NY for medical oncology
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
57,750 | $1 | $2 |
| Denosumab injection (Prolia/Xgeva) | 2,160 | $18 | $33 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,000 | $6 | $22 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
515 | $91 | $202 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
470 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 310 | $1 | $57 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
159 | $10 | $40 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
96 | $48 | $114 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
91 | $22 | $63 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
91 | $95 | $248 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $117 | $265 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
51 | $1 | $9 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
39 | $101 | $223 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $38 | $143 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
33 | $49 | $125 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
23 | $41 | $88 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
22 | $68 | $142 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
19 | $16 | $44 |
| New patient office visit, complex (60-74 min) | 15 | $169 | $335 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
90.8% high complexity
8.1% medium
1.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$49,832
Total received (2018-2024)
Avg $7,119/year across 7 years
Top 24% in NY for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
751
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$26,772
2023
$16,242
2022
$919
2021
$320
2020
$774
2019
$2,031
2018
$2,773
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$12,100
GlaxoSmithKline, LLC.
$11,550
E.R. Squibb & Sons, L.L.C.
$336
ABBVIE INC.
$282
Eisai Inc.
$260
Merck Sharp & Dohme LLC
$224
Janssen Biotech, Inc.
$147
Novartis Pharmaceuticals Corporation
$142
Daiichi Sankyo Inc.
$142
Takeda Pharmaceuticals U.S.A., Inc.
$138
Aveo Pharmaceuticals, Inc.
$130
PUMA BIOTECHNOLOGY, INC.
$127
Astellas Pharma Global Development
$102
Astellas Pharma US Inc
$96
Ipsen Biopharmaceuticals, Inc
$95
Adaptive Biotechnologies Corporation
$78
Bayer Healthcare Pharmaceuticals Inc.
$76
Genentech USA, Inc.
$71
PFIZER INC.
$61
SERVIER PHARMACEUTICALS LLC
$58
Acrotech Biopharma Inc.
$49
Lilly USA, LLC
$47
BeiGene USA, Inc.
$45
EMD Serono, Inc.
$43
GENZYME CORPORATION
$40
Celgene Corporation
$32
Genmab U.S., Inc.
$31
ARRAY BIOPHARMA INC
$31
Blueprint Medicines Corporation
$25
Amgen Inc.
$25
SpringWorks Therapeutics, Inc.
$24
Stemline Therapeutics Inc.
$24
Regeneron Healthcare Solutions, Inc.
$20
Exelixis Inc.
$19
Spectrum Pharmaceuticals Inc.
$18
TerSera Therapeutics LLC
$18
TAIHO ONCOLOGY, INC.
$17
Rigel Pharmaceuticals, Inc.
$17
Mirati Therapeutics, Inc.
$17
Karyopharm Therapeutics Inc.
$17
Top 3 companies account for 89.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$16,549
GlaxoSmithKline, LLC.
$11,579
Merck Sharp & Dohme LLC
$7,977
Regeneron Healthcare Solutions, Inc.
$2,639
E.R. Squibb & Sons, L.L.C.
$1,189
Janssen Biotech, Inc.
$824
Novartis Pharmaceuticals Corporation
$792
PFIZER INC.
$731
Astellas Pharma US Inc
$571
Genentech USA, Inc.
$566
Merck Sharp & Dohme Corporation
$442
Daiichi Sankyo Inc.
$404
Eisai Inc.
$355
Amgen Inc.
$353
Lilly USA, LLC
$305
Celgene Corporation
$287
ABBVIE INC.
$282
Pharmacyclics LLC, An AbbVie Company
$261
Takeda Pharmaceuticals U.S.A., Inc.
$220
Sirtex Medical Inc
$204
Bayer HealthCare Pharmaceuticals Inc.
$143
Adaptive Biotechnologies Corporation
$136
Aveo Pharmaceuticals, Inc.
$130
PUMA BIOTECHNOLOGY, INC.
$127
EISAI INC.
$127
Incyte Corporation
$113
GENZYME CORPORATION
$111
EMD Serono, Inc.
$108
Gilead Sciences, Inc.
$107
Dendreon Pharmaceuticals LLC
$103
Astellas Pharma Global Development
$102
Bayer Healthcare Pharmaceuticals Inc.
$97
Ipsen Biopharmaceuticals, Inc
$95
SERVIER PHARMACEUTICALS LLC
$82
ARRAY BIOPHARMA INC
$82
AbbVie, Inc.
$78
Exelixis Inc.
$73
Puma Biotechnology, Inc.
$68
Rigel Pharmaceuticals, Inc.
$67
Karyopharm Therapeutics Inc.
$57
Genmab U.S., Inc.
$54
CTI BioPharma Corp.
$53
Shire North American Group Inc
$53
TerSera Therapeutics LLC
$50
Apellis Pharmaceuticals, Inc.
$49
Acrotech Biopharma Inc.
$49
MorphoSys, US Inc.
$49
Kite Pharma, Inc.
$48
Seattle Genetics, Inc.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
BeiGene USA, Inc.
$45
Coherus Biosciences Inc.
$40
Telix Pharmaceuticals
$37
Janssen Pharmaceuticals, Inc
$37
Alexion Pharmaceuticals, Inc.
$37
Pharmacosmos Therapeutics Inc.
$35
Myriad Genetic Laboratories, Inc.
$32
Clovis Oncology, Inc.
$32
TESARO, Inc.
$31
TAIHO ONCOLOGY, INC.
$31
Heron Therapeutics, Inc.
$30
JAZZ PHARMACEUTICALS INC.
$29
Seagen Inc.
$28
SANOFI-AVENTIS U.S. LLC
$28
Blueprint Medicines Corporation
$25
SpringWorks Therapeutics, Inc.
$24
Stemline Therapeutics Inc.
$24
Fresenius Kabi USA, LLC
$22
Global Blood Therapeutics, Inc.
$19
Spectrum Pharmaceuticals Inc.
$18
AVEO Pharmaceuticals, Inc.
$18
Sandoz Inc.
$17
AbbVie Inc.
$17
Mirati Therapeutics, Inc.
$17
Helsinn Therapeutics (U.S.), Inc.
$17
Ethicon US, LLC
$15
SOBI, INC
$15
Sun Pharmaceutical Industries Inc.
$15
Verastem, Inc.
$13
Lexicon Pharmaceuticals, Inc.
$13
Dova Pharmaceuticals
$13
Taiho Oncology, Inc.
$12
ADC Therapeutics America, Inc.
$11
Top 3 companies account for 72.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BELEODAQ · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CEREZYME · CHANTIX · CINVANTI · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · Erleada · FEIBA · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Herceptin · IBRANCE · ICLUSIG · IDHIFA · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INVEGA SUSTENNA · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MOVANTIK · MYLOTARG · MYRISK · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OBIZUR · ODOMZO · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Oncaspar · Onivyde · Orserdu · PEMAZYRE · PIQRAY · PRECISETUMOR · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUTENT · Stimufend · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · Tavalisse · Tazverik · Tecentriq · Tibsovo · Tivdak · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZARXIO · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
8
County median income
$74,740
Nearest hospital to ZIP centroid (approximate)
ST JOSEPH'S HOSPITAL HEALTH CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khadim is a mixed practice specialist, with above-average Medicare volume (top 2% in NY), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khadim experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Khadim performed 57,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khadim receive payments from pharmaceutical companies?
Yes. Dr. Khadim received a total of $49,832 from 83 companies across 751 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khadim's costs compare to other medical oncologists in Syracuse?
Dr. Khadim's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khadim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Syracuse
Browse medical oncologists in Syracuse ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in NY
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in NY
Which NY medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology